Association Between Anti-Tuberculosis Drug Side Effects and Medication Adherence Among Pulmonary Tuberculosis Patients at Wijaya Kusumah Hospital, Kuningan, Indonesia
DOI:
https://doi.org/10.69930/ajer.v3i2.846Keywords:
Tuberculosis, Anti-Tuberculosis Drugs, Drug Side Effects, Medication Adherence, MMAS-8Abstract
Tuberculosis (TB) remains one of the leading infectious diseases worldwide and continues to be a major public health concern in Indonesia. The success of anti-tuberculosis treatment depends largely on patients' adherence to medication. However, the occurrence of adverse drug reactions during treatment may reduce adherence and compromise treatment outcomes. This study aimed to determine the association between anti-tuberculosis drug side effects and medication adherence among pulmonary tuberculosis patients at Wijaya Kusumah Hospital, Kuningan. A quantitative observational study with a cross-sectional design was conducted among pulmonary tuberculosis patients receiving anti-tuberculosis treatment at Wijaya Kusumah Hospital, Kuningan. A total of 52 respondents were recruited using total sampling. ADRs were assessed using a structured questionnaire, while medication adherence was measured using the eight-item Morisky Medication Adherence Scale (MMAS-8). Data were analyzed using the Chi-square test with a significance level of 0.05. Most respondents experienced severe ADRs (57.7%), while 63.5% demonstrated low medication adherence. Statistical analysis showed a significant association between ADRs and medication adherence (p = 0.040). Patients who experienced more severe ADRs were more likely to demonstrate poor adherence during treatment. ADRs were significantly associated with medication adherence among pulmonary tuberculosis patients. Early identification and appropriate management of adverse drug reactions are essential to improve medication adherence and enhance treatment success. Improving medication adherence and reducing treatment failure may contribute to decreasing the transmission of drug-resistant tuberculosis within communities, protecting vulnerable populations, supporting Sustainable Development Goal (SDG) 3 (Good Health and Well-being), and strengthening health systems in resource-limited settings such as Indonesia.
References
1. World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization; 2024.
2. Ministry of Health of the Republic of Indonesia. Indonesia tuberculosis profile 2024. Jakarta: Ministry of Health of the Republic of Indonesia; 2024.
3. Burhan E, Isbaniyah F, Sinaga BYM, et al. Guidelines for the diagnosis and management of tuberculosis in Indonesia. Jakarta: Indonesian Society of Respirology; 2021.
4. Christy BA, Susanti R, Nurmainah. Relationship between medication adherence and adverse effects of anti-tuberculosis drugs among tuberculosis patients. Journal of Syifa Sciences and Clinical Research. 2022;4(2):484–493.
5. Dwiningrum R, Wulandari RY, Yunitasari E. Relationship between knowledge, duration of treatment, and medication adherence among pulmonary tuberculosis patients. Jurnal Aisyah: Jurnal Ilmu Kesehatan. 2021;6(Special Issue):209–214.
6. Yudiana R, Zulmansyah Z, Garna H. Relationship between adherence to fixed-dose combination anti-tuberculosis therapy and treatment outcomes among adult pulmonary tuberculosis patients. Jurnal Integrasi Kesehatan dan Sains. 2022;4(1):44–49.
7. Elizah E, Zaman C, Wahyudi A. Analysis of medication adherence among pulmonary tuberculosis patients. Jurnal Kesehatan. 2024;9(1):176–187.
8. Kusmiyani OT. Factors associated with adherence to anti-tuberculosis medication among pulmonary tuberculosis patients. Journal of Public Health Research. 2024;5(2):85–93.
9. Mahyani, Zulkarnaini, Adriani L. Relationship between knowledge and motivation with medication adherence among pulmonary tuberculosis patients. Jurnal Ilmiah Kesehatan. 2024;6(2):134–149.
10. Zazzara MB, Palmer K, Vetrano DL, Carfì A, Graziano O. Adverse drug reactions in older adults: a narrative review of the literature. European Geriatric Medicine. 2021;12(3):463–473.
11. Oktaviani R. Faktor-Faktor yang Berhubungan dengan Kepatuhan Minum Obat Penderita Tuberkulosis Paru di Puskesmas Jatiuwung Kota Tangerang Tahun 2016 [undergraduate thesis]. Jakarta: Universitas Esa Unggul; 2017.
12. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical Hypertension. 2008;10(5):348–354.
13. World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization; 2020.
14. Ministry of Health of the Republic of Indonesia. National Guidelines for Tuberculosis Medical Management. Jakarta: Ministry of Health of the Republic of Indonesia; 2020.
15. Indonesian Society of Respirology. Guidelines for Tuberculosis Management. Jakarta: Indonesian Society of Respirology; 2021.
16. Rianto L, Agustina I, Alfian SD, Iskandarsyah A, Pradipta IS, Abdulah R. Development and validation of a structured questionnaire for assessing risk factors of medication non-adherence among pulmonary tuberculosis patients in Indonesia. Frontiers in Pharmacology. 2024;14:1257353. doi:10.3389/fphar.2023.1257353
17. Wang Y, Jian S, Huang Z, Chen H, Hu Y, Fang S. Medication-related burden and its association with medication adherence among elderly tuberculosis patients in Guizhou, China: a cross-sectional study. Frontiers in Pharmacology. 2024;15:1416005. doi:10.3389/fphar.2024.1416005.
18. Davis RA, Leavitt HB, Singh A, Fanouraki E, Yen RW, Bratches RW. Examining interventions that aim to enhance TB treatment adherence in Southeast Asia: a systematic review and meta-analysis. Indian Journal of Tuberculosis. 2024;71(1):48–63. doi:10.1016/j.ijtb.2023.03.001.
19. Susilo R, Azzahra DN, Indawati I, Bachtiar A, Setyaningsih I, Rohadi D, et al. The Longer the Therapy, the Worse the Severity of the Adverse Drug Reactions that Occur in Drug-Resistant Pulmonary Tuberculosis Patients. Indian Journal of Tuberculosis. 2024;71(Suppl 1):S97–S100. doi:10.1016/j.ijtb.2024.06.001.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Vera Mulyawantie, Juju Jumiati, Fitri Indrayani
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
